More orally active than rutin. Vaso- and cardioprotective agent used clinically to treat venous disorders. Inhibits platelet aggregation. Protects biomembranes and DNA against the deleterious effects of γ-radiation. Free radical scavenger. Antioxidant.
Product Details
| Alternative Name: | Troxerutin |
| |
| Formula: | C33H42O19 |
| |
| MW: | 742.7 |
| |
| Source: | Semisynthetic. |
| |
| CAS: | 7085-55-4 |
| |
| MI: | 14: 9789 |
| |
| RTECS: | LK8331500 |
| |
| Purity: | ≥95% (Assay) |
| |
| Appearance: | Light yellow to greenish powder. |
| |
| Solubility: | Soluble in water, glycerol or propylene glycol. |
| |
| Shipping: | Ambient Temperature |
| |
| Long Term Storage: | -20°C |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Please mouse over
Product Literature References
Protection of cellular DNA from gamma-radiation-induced damages and enhancement in DNA repair by troxerutin: D.K. Maurya, et al.; Mol. Cell. Biochem.
280, 57 (2005),
Abstract;
Radioprotection of normal tissues in tumor-bearing mice by troxerutin: D.K. Maurya, et al.; J. Radiat. Res.
45, 221 (2004),
Abstract;
Full Text
Free radical scavenging and skin penetration of troxerutin and vitamin derivatives: M. Kessler, et al.; J. Dermatolog. Treat.
13, 133 (2002),
Abstract;
Effect of troxerutin and methionine on spin trapping of free oxy-radicals: I.E. Blasig, et al.; Biomed. Biochim. Acta
47, S252 (1988),
Abstract;
Antiaggregatory effects of flavonoids in vivo and their influence on lipoxygenase and cyclooxygenase in vitro: J. Swies, et al.; Pol. J. Pharmacol. Pharm.
36, 455 (1984),
Abstract;
